Commonly, the AKT proteins or proteins within the PI3K/AKT/mTOR signaling pathway are the target of study for the development of pharmacological therapies against several types of cancer, since it has been demonstrated that these proteins participate in biological processes which are key for the cell, such as growth, differentiation, and survival [26]. Here, AKT1 is linked to cancer.